Compare, Analyse Fulford India with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs TEVA PHARMA (Israel) - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FULFORD INDIA   TEVA PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
TEVA PHARMA
Dec-13
FULFORD INDIA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs9423,072-   
Low Rs4502,668-   
Sales per share (Unadj.) Rs691.41,762.9-  
Earnings per share (Unadj.) Rs11.5110.1-  
Cash flow per share (Unadj.) Rs15.4252.6-  
Dividends per share (Unadj.) Rs2.0096.40-  
Dividend yield (eoy) %0.33.4 8.6%  
Book value per share (Unadj.) Rs380.01,958.2-  
Shares outstanding (eoy) m3.90848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.6 61.8%   
Avg P/E ratio x60.726.1 233.0%  
P/CF ratio (eoy) x45.311.4 398.9%  
Price / Book Value ratio x1.81.5 125.0%  
Dividend payout %17.487.5 19.9%   
Avg Mkt Cap Rs m2,7142,433,768 0.1%   
No. of employees `0000.444.9 1.0%   
Total wages/salary Rs m5050-   
Avg. sales/employee Rs Th6,073.033,260.8 18.3%   
Avg. wages/employee Rs Th1,137.40-   
Avg. net profit/employee Rs Th100.72,077.8 4.8%   
INCOME DATA
Net Sales Rs m2,6961,494,907 0.2%  
Other income Rs m1250-   
Total revenues Rs m2,8221,494,907 0.2%   
Gross profit Rs m-46409,381 -0.0%  
Depreciation Rs m15120,835 0.0%   
Interest Rs m1029,362 0.0%   
Profit before tax Rs m54259,184 0.0%   
Minority Interest Rs m01,177 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-170,140 0.0%   
Tax Rs m10-3,164 -0.3%   
Profit after tax Rs m4593,386 0.0%  
Gross profit margin %-1.727.4 -6.3%  
Effective tax rate %17.7-1.2 -1,448.1%   
Net profit margin %1.76.2 26.5%  
BALANCE SHEET DATA
Current assets Rs m1,7381,009,655 0.2%   
Current liabilities Rs m545880,504 0.1%   
Net working cap to sales %44.38.6 512.4%  
Current ratio x3.21.1 278.3%  
Inventory Days Days4891 53.4%  
Debtors Days Days496 4.5%  
Net fixed assets Rs m12488,270 0.0%   
Share capital Rs m393,680 1.1%   
"Free" reserves Rs m1,4430-   
Net worth Rs m1,4821,660,558 0.1%   
Long term debt Rs m0764,379 0.0%   
Total assets Rs m2,0773,416,342 0.1%  
Interest coverage x6.79.8 68.3%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.30.4 296.7%   
Return on assets %2.63.6 72.6%  
Return on equity %3.05.6 53.6%  
Return on capital %4.34.9 87.3%  
Exports to sales %00-   
Imports to sales %24.50-   
Net fx Rs m-6560-   
CASH FLOW
From Operations Rs m90238,211 0.0%  
From Investments Rs m105-84,408 -0.1%  
From Financial Activity Rs m-14-285,750 0.0%  
Net Cashflow Rs m181-131,947 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 73.59 Rs / USD

Compare FULFORD INDIA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare FULFORD INDIA With: ELDER PHARMA  ALEMBIC PHARMA  VENUS REMEDIES  FRESENIUS KABI ONCO.  IPCA LABS  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views On News

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FULFORD INDIA

FULFORD INDIA - DISHMAN PHARMA COMPARISON

COMPARE FULFORD INDIA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS